Eu-Jin Ang

Executive Director, Corporate Risk Advisory / Global Markets Structuring at Crédit Agricole Corporate & Investment Bank (CA-CIB)

📍 London, England, United Kingdom🔄 Updated September 2026💼 8 investments📅 11 years investing🗓 Last invested Nov 2023
VC🌍 United Kingdom
8
Total investments
2
Early stage
2
Mid stage
3
Late stage
11y
Years active

Portfolio

8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Nov 2023
Fuse develops and manufactures innovative diagnostic products for a range of industries delivering lab quality information wherever it is needed through ultra-rapid, low-cost tests. The immunoassay and PCR technologies that dominate the diagnostics industry have consistently failed to deliver lab-quality tests that are suitable for widespread decentralised use. Using an all-new multianalytic chemistry and breakthrough product innovations Fuse has overcome the cost and performance challenges of established approaches to make accurate, point-of-need testing a reality for all.
Angel Investor
Nov 2021
Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa
late stageBiotechnology
Angel investor
Apr 2019
Rotaheat delivers clean heat through our novel technology, converting motive power (mechanical energy) directly into heated fluids at over 100C. Rotaheat solves the energy and environmental challenges of providing heat with zero greenhouse gas emissions through our highly efficient and compact technology, delivering heat that is cost comparable to mains supply gas. The technology is unique (patents granted) compared with the competitive alternatives which either contribute greenhouse gas emissions or are unable to supply heat during the periods of greatest demand for heat. Rotaheat Ltd is a limited company registered in England and Wales under company registration number 08328950. Contact us at info [at] rotaheat.co.uk
Angel investor
Jun 2018
Celixir (formerly known as Cell Therapy Ltd.) is a private British regenerative medicine company that discovers and develops life-saving and life-altering regenerative medicines for patients with the greatest medical need. Celixir, founded in 2009, is made up of a world-class team of scientists and biopharmaceutical executives, led by Nobel Laureate Professor Sir Martin Evans and former Roche Global Head of Emerging Technologies, Ajan Reginald. Celixir’s unique platform technology allows us to adopt an ‘off-the-shelf’ approach to deliver regenerative medicines to patients.
Angel investor
Mar 2016
Sense is transforming healthcare by redefining diagnostics. Founded in 2014, we strive to improve lives by bringing powerful tools for fast, accurate, and accessible diagnostics to all. We’re focused on creating a portfolio of unconstrained, instrument-free molecular diagnostic technologies. Our Veros™ platform introduces novel and proprietary rapid molecular amplification technology to detect a variety of deadly and costly diseases. We’re developing technologies that combine the power of laboratory tests with the simplicity and ease of use of products because we believe that if you can test anywhere, you can change everything.* *Professional use, patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Angel investor
Jun 2015
Desktop Genetics is an international company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library product range, which enables the work of our pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics'​ tools and technologies are used by over 1800 organisations all over the world, and our projects contribute directly to several key partnerships to bring CRISPR into the clinic.
mid stageBiotechnology
Angel investor
Mar 2015
Complete Mathematics is working with schools, colleges and families to give pupils of all ages the best possible mathematics education. Our suite of products consists of TUTOR, CLASSROOM and CPD. TUTOR: The world's first digital tutor for mathematics ensures that all pupils, students, and learners everywhere can have all the benefits of 1-to-1 personal tuition at a fraction of the cost. Covering every aspect of mathematics and suitable for all age groups, TUTOR gives 24-7 access to adaptive, intelligent, highly personalised mathematics instruction and quizzing from leading mathematics expert teachers. CLASSROOM: The most comprehensive platform for teachers of mathematics, giving detailed support for every single lesson from counting to calculus, with activities for pupils to do online, making homework setting, tracking and monitoring a breeze. CPD: The most extensive library of training courses for everyone teaching mathematics. Teachers at all stages in their careers can access anytime, anywhere high quality training for expert mathematics educators. In addition to the online library, MathsConf is the largest gathering of mathematics teachers, with conferences taking place 5 times per year.
Angel investor
Jan 2015
LaunchPad is now Harver. Harver is the industry leading hiring solution helping organizations optimize their talent decisions. Rooted in over 35 years of rich data insights backed by I/O psychology and cognitive science, Harver delivers a suite of automated solutions that enables organizations to engage, hire, and develop the right talent in a fast and fundamentally less biased way. Having processed over 100 million candidates, Harver provides trusted, data-driven, and adaptable offerings, including assessments, video interviews, scheduling, and reference checking. Harver has helped more than 1,300 customers, including Booking.com, Peloton, Valvoline, and McDonald’s, take the smart path to the right talent.
Experience · 10 entries
All (10)
Investments (8)
2023
Angel Investor
Nov 2023
Fuse develops and manufactures innovative diagnostic products for a range of industries delivering lab quality information wherever it is needed through ultra-rapid, low-cost tests. The immunoassay and PCR technologies that dominate the diagnostics industry have consistently failed to deliver lab-quality tests that are suitable for widespread decentralised use. Using an all-new multianalytic chemistry and breakthrough product innovations Fuse has overcome the cost and performance challenges of established approaches to make accurate, point-of-need testing a reality for all.
2021
Angel Investor
Nov 2021
Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa
late stageBiotechnology
2019
Angel investor
Apr 2019
Rotaheat delivers clean heat through our novel technology, converting motive power (mechanical energy) directly into heated fluids at over 100C. Rotaheat solves the energy and environmental challenges of providing heat with zero greenhouse gas emissions through our highly efficient and compact technology, delivering heat that is cost comparable to mains supply gas. The technology is unique (patents granted) compared with the competitive alternatives which either contribute greenhouse gas emissions or are unable to supply heat during the periods of greatest demand for heat. Rotaheat Ltd is a limited company registered in England and Wales under company registration number 08328950. Contact us at info [at] rotaheat.co.uk
2018
Angel investor
Jun 2018
Celixir (formerly known as Cell Therapy Ltd.) is a private British regenerative medicine company that discovers and develops life-saving and life-altering regenerative medicines for patients with the greatest medical need. Celixir, founded in 2009, is made up of a world-class team of scientists and biopharmaceutical executives, led by Nobel Laureate Professor Sir Martin Evans and former Roche Global Head of Emerging Technologies, Ajan Reginald. Celixir’s unique platform technology allows us to adopt an ‘off-the-shelf’ approach to deliver regenerative medicines to patients.
2016
Angel investor
Mar 2016
Sense is transforming healthcare by redefining diagnostics. Founded in 2014, we strive to improve lives by bringing powerful tools for fast, accurate, and accessible diagnostics to all. We’re focused on creating a portfolio of unconstrained, instrument-free molecular diagnostic technologies. Our Veros™ platform introduces novel and proprietary rapid molecular amplification technology to detect a variety of deadly and costly diseases. We’re developing technologies that combine the power of laboratory tests with the simplicity and ease of use of products because we believe that if you can test anywhere, you can change everything.* *Professional use, patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Show all 10 entries ↓
Investment activity
2015–2023 · 8 investments
201532016120181201912021120231
Recent (last 2 years)Earlier